Asset Details
Do you wish to reserve the book?
Spatial extent as a sensitive amyloid‐PET metric in preclinical Alzheimer's disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Spatial extent as a sensitive amyloid‐PET metric in preclinical Alzheimer's disease
Do you wish to request the book?
Spatial extent as a sensitive amyloid‐PET metric in preclinical Alzheimer's disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Spatial extent as a sensitive amyloid‐PET metric in preclinical Alzheimer's disease
2024
Overview
INTRODUCTION Spatial extent‐based measures of how far amyloid beta (Aβ) has spread throughout the neocortex may be more sensitive than traditional Aβ‐positron emission tomography (PET) measures of Aβ level for detecting early Aβ deposits in preclinical Alzheimer's disease (AD) and improve understanding of Aβ’s association with tau proliferation and cognitive decline. METHODS Pittsburgh Compound‐B (PIB)‐PET scans from 261 cognitively unimpaired older adults from the Harvard Aging Brain Study were used to measure Aβ level (LVL; neocortical PIB DVR) and spatial extent (EXT), calculated as the proportion of the neocortex that is PIB+. RESULTS EXT enabled earlier detection of Aβ deposits longitudinally confirmed to reach a traditional LVL‐based threshold for Aβ+ within 5 years. EXT improved prediction of cognitive decline (Preclinical Alzheimer Cognitive Composite) and tau proliferation (flortaucipir‐PET) over LVL. DISCUSSION These findings indicate EXT may be more sensitive to Aβ’s role in preclinical AD than level and improve targeting of individuals for AD prevention trials. Highlights Aβ spatial extent (EXT) was measured as the percentage of the neocortex with elevated Pittsburgh Compound‐B. Aβ EXT improved detection of Aβ below traditional PET thresholds. Early regional Aβ deposits were spatially heterogeneous. Cognition and tau were more closely tied to Aβ EXT than Aβ level. Neocortical tau onset aligned with reaching widespread neocortical Aβ.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
/ Aged
/ Aging
/ Alzheimer Disease - diagnostic imaging
/ Alzheimer Disease - metabolism
/ Alzheimer Disease - pathology
/ amyloid
/ Amyloid beta-Peptides - metabolism
/ Brain
/ Cognitive Dysfunction - diagnostic imaging
/ Cognitive Dysfunction - metabolism
/ Disease
/ Female
/ Humans
/ Male
/ Neocortex - diagnostic imaging
/ Positron emission tomography
/ Positron emission tomography (PET)
/ preclinical Alzheimer's disease
/ Regions
/ tau PET
